[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"app-context":3,"blog-moderna-sinks-another-8-even-as-lead-investigator-calls-melanoma-vaccine-data-transformational-ES":222},{"languages":4,"categories":41,"products":125,"competitors":149},[5,9,13,17,21,25,29,33,37],{"name":6,"code":7,"id":8},"English","EN","TGFuZ3VhZ2U6ZW4=",{"name":10,"code":11,"id":12},"Español","ES","TGFuZ3VhZ2U6ZXM=",{"name":14,"code":15,"id":16},"Português","PT","TGFuZ3VhZ2U6cHQ=",{"name":18,"code":19,"id":20},"日本語","JA","TGFuZ3VhZ2U6amE=",{"name":22,"code":23,"id":24},"한국어","KO","TGFuZ3VhZ2U6a28=",{"name":26,"code":27,"id":28},"Deutsch","DE","TGFuZ3VhZ2U6ZGU=",{"name":30,"code":31,"id":32},"Italiano","IT","TGFuZ3VhZ2U6aXQ=",{"name":34,"code":35,"id":36},"Français","FR","TGFuZ3VhZ2U6ZnI=",{"name":38,"code":39,"id":40},"中文 (中国)","ZH","TGFuZ3VhZ2U6emg=",[42,73,104],{"icon":43,"slug":44,"title":45,"description":46,"featuredLinks":47},"mingcute:stock-line","stock-market-basics","Stock Market Basics","\u003Cp>Beginners' guides and practical tips for understanding stock market investing.\u003C\u002Fp>\n",[48,53,58,63,68],{"url":49,"title":50,"description":51,"ogImage":52},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-makes-stocks-go-up-and-down","What Makes Stocks Go Up and Down | TIKR.com","Understanding what makes stock prices go up and down can help investors better navigate investing. Click to learn more!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-makes-stocks-go-up-and-down-banner\u002FWhat-makes-stocks-go-up-and-down-banner.jpg?_i=AA",{"url":54,"title":55,"description":56,"ogImage":57},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fdividend-yield-meaning-formula-example","Dividend Yield: Meaning, Formula, Example | Tikr.com Blog | TIKR.com","The dividend yield is a key metric for investors looking to gauge the income potential of their investments. It measures how much a company pays out in","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FDividend-yield\u002FDividend-yield.png?_i=AA",{"url":59,"title":60,"description":61,"ogImage":62},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fmarket-capitalization-definition-formula-and-why-it-matters","Market Capitalization: Definition, Formula, and Why It Matters | TIKR.com","Long-term investors often look at various valuation metrics when deciding whether to invest in a particular company. One helpful metric to evaluate is","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FMarket-Capitalization-Definition-Formula-and-Why-It-Matters\u002FMarket-Capitalization-Definition-Formula-and-Why-It-Matters.png?_i=AA",{"url":64,"title":65,"description":66,"ogImage":67},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fearnings-per-share-definition-formula-and-why-eps-matters","Earnings Per Share: Definition, Formula, and Why EPS Matters | TIKR.com","Earnings Per Share (EPS) represents the portion of a company's net earnings allocated to each share. Click to learn more!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEPS-Defiinition-formula-and-why-EPS-matters-1\u002FEPS-Defiinition-formula-and-why-EPS-matters-1.png?_i=AA",{"url":69,"title":70,"description":71,"ogImage":72},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-stock-price-target","What Is a Stock Price Target? | TIKR.com","A price target is a stock's estimated future price. It can help investors quickly find undervalued stocks. Learn more now!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-Stock-Price-Target-2\u002FWhat-is-a-Stock-Price-Target-2.png?_i=AA",{"icon":74,"slug":75,"title":76,"description":77,"featuredLinks":78},"material-symbols:analytics-outline","fundamental-analysis","Fundamental Analysis","\u003Cp>In-depth resources and financial metrics to help you evaluate companies like a pro.\u003C\u002Fp>\n",[79,84,89,94,99],{"url":80,"title":81,"description":82,"ogImage":83},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fshare-repurchase-why-do-companies-buy-back-their-stock","Share Repurchase: Why Do Companies Buy Back Their Stock? | TIKR.com","Share repurchases, or share buybacks, have gained popularity in the last two decades. According to a report from Goldman Sachs, stock buybacks initiated","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FTIKR-BLOG-COVER-PHOTOS-3_544a7f4e\u002FTIKR-BLOG-COVER-PHOTOS-3_544a7f4e.png?_i=AA",{"url":85,"title":86,"description":87,"ogImage":88},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-return-on-invested-capital","What Is a Good Return on Invested Capital? | TIKR.com","Learning about Return on Invested Capital (ROIC) can help investors spot highly profitable stocks that can drive long-term returns. Learn more now!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-return-on-Invested-capital\u002FWhat-is-a-good-return-on-Invested-capital.png?_i=AA",{"url":90,"title":91,"description":92,"ogImage":93},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-return-on-equity-ratio","What is a Good Return on Equity Ratio | Tikr.com Blog | TIKR.com","Return on Equity (ROE) is a financial ratio that reflects a company's profitability in relation to the equity invested by shareholders. It basically","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-return-on-equity-ratio-1\u002FWhat-is-a-good-return-on-equity-ratio-1.jpg?_i=AA",{"url":95,"title":96,"description":97,"ogImage":98},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-p-e-ratio","What Is a Good P\u002FE Ratio? | TIKR.com","Financial analysts and investors look at various metrics before deciding whether a stock is a buy. One of the metrics is the price-to-earnings ratio (P\u002FE","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-PE-ratio-1\u002FWhat-is-a-good-PE-ratio-1.jpg?_i=AA",{"url":100,"title":101,"description":102,"ogImage":103},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Ftop-6-metrics-for-investing-in-reits","Top 6 Metrics for Investing in REITs | TIKR.com","Real estate has been one of the greatest asset classes for wealth creation in history, and investing in Real Estate Investment Trusts (REITs) can allow","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FGroup-10\u002FGroup-10.png?_i=AA",{"icon":105,"slug":106,"title":107,"description":108,"featuredLinks":109},"hugeicons:investigation","investing-lingo","Investing Lingo","\u003Cp>A comprehensive glossary of investing terms and jargon so you can speak the language of the markets confidently.\u003C\u002Fp>\n",[110,115,120],{"url":111,"title":112,"description":113,"ogImage":114},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fenterprise-value-definition-and-calculation","Enterprise Value: Definition and Calculation | Tikr.com Blog | TIKR.com","Enterprise value (EV) is a financial metric that offers a comprehensive snapshot of a company's total value. Unlike market capitalization which solely","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEnterprise-Value-Definition-and-Calculation_37576e40\u002FEnterprise-Value-Definition-and-Calculation_37576e40.png?_i=AA",{"url":116,"title":117,"description":118,"ogImage":119},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Febitda-definition-formula-how-to-use-it","EBITDA: Definition, Formula, How to Use It | TIKR.com","EBITDA stands for earnings before interest, taxes, depreciation and amortization. It's a financial metric commonly used to evaluate a company's financial","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEBITDA-Definition-Formula-How-to-Use-It\u002FEBITDA-Definition-Formula-How-to-Use-It.png?_i=AA",{"url":121,"title":122,"description":123,"ogImage":124},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-the-free-cash-flow-formula-and-why-does-it-matter","What is the Free Cash Flow Formula and Why Does It Matter | TIKR.com","Free cash flow, or FCF, is the cash a company generates after it accounts for outflows required to maintain business operations and support capital","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-the-free-cash-flow-formula\u002FWhat-is-the-free-cash-flow-formula.png?_i=AA",[126,130,134,137,141,145],{"slug":127,"modified":128,"title":129},"valuation-model-builder","2025-07-03T00:18:53","Value Stocks Quickly and Accurately",{"slug":131,"modified":132,"title":133},"stock-portfolio-tracking","2024-12-02T22:21:28","Monitor Your Portfolio",{"slug":75,"modified":135,"title":136},"2025-01-21T22:10:52","Instantly Analyze Companies with In-Depth Metrics",{"slug":138,"modified":139,"title":140},"stock-screener","2024-12-02T22:13:31","Find the Best Stocks to Buy",{"slug":142,"modified":143,"title":144},"investor-stock-portfolio","2025-01-21T22:02:56","Follow Investment Moves of Top Investors",{"slug":146,"modified":147,"title":148},"analyze-stocks","2025-07-23T16:04:24","Analyze Stocks",[150,154,158,162,166,170,174,178,182,186,190,194,198,202,206,210,214,218],{"slug":151,"title":152,"modified":153},"bloomberg","Bloomberg","2025-01-16T14:23:44",{"slug":155,"title":156,"modified":157},"morningstar","Morningstar","2025-01-16T14:25:16",{"slug":159,"title":160,"modified":161},"sentieo","Sentieo","2025-01-16T17:58:27",{"slug":163,"title":164,"modified":165},"googlefinance","Google Finance","2025-01-17T19:39:37",{"slug":167,"title":168,"modified":169},"tradingview","TradingView","2025-01-16T18:17:01",{"slug":171,"title":172,"modified":173},"factset","Factset","2025-01-16T18:20:16",{"slug":175,"title":176,"modified":177},"finviz","Finviz","2025-01-16T18:23:40",{"slug":179,"title":180,"modified":181},"ycharts","YCharts","2025-01-16T18:32:19",{"slug":183,"title":184,"modified":185},"marketbeat","MarketBeat","2025-03-11T00:27:23",{"slug":187,"title":188,"modified":189},"benzinga","Benzinga","2025-03-11T00:31:00",{"slug":191,"title":192,"modified":193},"gurufocus","Gurufocus","2025-03-11T00:31:12",{"slug":195,"title":196,"modified":197},"fast-graphs","FAST Graphs","2025-03-11T00:31:19",{"slug":199,"title":200,"modified":201},"tipranks","TipRanks","2025-03-11T00:31:26",{"slug":203,"title":204,"modified":205},"seeking-alpha","Seeking Alpha","2025-03-11T00:31:45",{"slug":207,"title":208,"modified":209},"thestreet","TheStreet","2025-03-11T00:31:52",{"slug":211,"title":212,"modified":213},"investing-com","Investing.com","2025-03-11T00:32:00",{"slug":215,"title":216,"modified":217},"zacks","Zacks","2025-03-26T15:40:40",{"slug":219,"title":220,"modified":221},"alphasense","AlphaSense","2025-03-11T00:32:15",{"post":223,"seo":256,"relatedPosts":263,"suggestedPosts":340},{"id":224,"title":225,"date":226,"modified":226,"excerpt":227,"content":228,"wordCount":229,"lang":230,"uri":231,"slug":232,"cloudinaryAssetId":233,"featuredImageOriginalUrl":234,"featuredImageMetadata":235,"author":238,"editor":244,"categories":247,"relatedPosts":253,"seo":254},145509,"Moderna Cae Otro 8% Aunque el Investigador Principal Califica los Datos de la Vacuna contra el Melanoma como \"Transformadores\"","2026-10-26T19:28:09","\u003Cp>Una verdadera victoria para los pacientes con melanoma, y aún una acción cara\u003C\u002Fp>","\u003Ch2 id=\"h-key-takeaways\" class=\"wp-block-heading\">Puntos Clave\u003C\u002Fh2>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>Las acciones de Moderna cayeron otro 8% esta mañana. El sábado, ella y su socia Merck presentaron los datos completos de la Fase 3 que muestran que su vacuna personalizada contra el melanoma redujo el riesgo de recurrencia o muerte en un 42%.\u003C\u002Fli>\n\n\n\n\u003Cli>La investigadora principal calificó los resultados de transformadores para el cáncer, pero la acción estaba valorada por más de un éxito en melanoma, y aún lo está.\u003C\u002Fli>\n\n\n\n\u003Cli>Moderna aún cotiza muy por encima de su múltiplo precio\u002Fventas forward promedio de cinco años, mientras que los analistas esperan solo $3.3 mil millones de ingresos en 2028.\u003C\u002Fli>\n\n\n\n\u003Cli>Los siguientes puntos de control serán los datos de seguimiento más prolongado y de supervivencia global, con Merck reportando el 29 de octubre y Moderna el 6 de noviembre.\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Moderna (\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fstock\u002Fabout?cid=128680956&tid=591065499\">MRNA\u003C\u002Fa>)\u003C\u002Fstrong> cayó otro 8% esta mañana. Esto a pesar de que la Dra. Georgina Long calificó los datos de la vacuna contra el melanoma que presentó el sábado como \"algo tan transformador para el cáncer\".\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Long, del Melanoma Institute Australia, dirigió el ensayo de Fase 3 de intismeran, la vacuna personalizada que Moderna está desarrollando con \u003Cstrong>Merck (\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fstock\u002Fabout?cid=288502&tid=2629738\">MRK\u003C\u002Fa>)\u003C\u002Fstrong>. La acción ya había perdido alrededor del 19% el jueves y viernes después de una \u003Ca href=\"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fmoderna-sinks-18-on-apparent-leak-of-embargoed-phase-3-melanoma-vaccine-data\">aparente filtración de los resultados\u003C\u002Fa>.\u003C\u002Fp>\n\n\n\n\u003Ch2 id=\"h-what-exactly-happened\" class=\"wp-block-heading\">Qué sucedió exactamente\u003C\u002Fh2>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">En la reunión de la Sociedad Europea de Oncología Médica del sábado, Long presentó los resultados para pacientes que ya habían sido sometidos a cirugía por melanoma. El ensayo probó intismeran más Keytruda de Merck frente a Keytruda solo:\u003C\u002Fp>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>Una reducción del 42% en el riesgo de recurrencia o muerte\u003C\u002Fli>\n\n\n\n\u003Cli>Una reducción del 38% en el riesgo de metástasis a distancia o muerte\u003C\u002Fli>\n\n\n\n\u003Cli>Un beneficio más fuerte después de seis meses\u003C\u002Fli>\n\n\n\n\u003Cli>Los datos de supervivencia global aún están por llegar\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Eso es importante. Incluso con Keytruda, el 44% de los pacientes en estadio III ven que su cáncer regresa o mueren dentro de los cinco años. Tres ensayos de Fase 3 que agregaron otras inmunoterapias a fármacos como Keytruda fracasaron.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>TIKR sigue a 23 analistas sobre Moderna. ¿Cuántos dicen \"Comprar\"?\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Vea el desglose completo de las calificaciones de Compra, Mantenimiento y Venta sobre Moderna, junto con las estimaciones de ingresos y ganancias de Wall Street, todo en un solo lugar. Más de 500,000 inversores usan TIKR para investigar acciones como esta. \u003Ca href=\"https:\u002F\u002Fwww.tikr.com\u002Fvaluation-model-builder?ref=tikrblog\">Vea las Calificaciones de los Analistas de Moderna\u003C\u002Fa>\u003C\u002Fp>\n\n\n\n\u003Ch2 id=\"h-the-bar-was-higher-for-the-stock\" class=\"wp-block-heading\">La expectativa era más alta para la acción\u003C\u002Fh2>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">En el ensayo de Fase 2 de Moderna, la reducción del riesgo fue del 49% después de cinco años de seguimiento. La acción también se había apreciado antes de estos resultados, impulsada por el \u003Ca href=\"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fmoderna-stock-soared-14-as-nih-plans-covid-style-push-for-cancer-vaccines\">plan del NIH para un impulso al estilo COVID en las vacunas contra el cáncer\u003C\u002Fa>. Así que el 42% se leyó como un paso atrás.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Al cierre del viernes, Moderna cotizaba a 42x ventas forward. Eso está por debajo de 52x el 21 de octubre, pero aún muy por encima de su promedio de cinco años de 7.7x.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg width=\"3024\" height=\"2016\" data-public-id=\"images\u002FMRNA-2026-10-26_MRNA_ntm_ps_5y\u002FMRNA-2026-10-26_MRNA_ntm_ps_5y.png\" loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_3024,h_2016,c_scale\u002Ff_webp,q_auto\u002Fv1793018831\u002Fimages\u002FMRNA-2026-10-26_MRNA_ntm_ps_5y\u002FMRNA-2026-10-26_MRNA_ntm_ps_5y.png?_i=AA\" alt=\"Gráfico de líneas de TIKR del múltiplo precio\u002Fventas forward (NTM) de Moderna, últimos 5 años.\" class=\"wp-post-145509 wp-image-145507\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1793018831\" data-seo=\"1\" srcset=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Ff_webp,q_auto\u002Fv1793018831\u002Fimages\u002FMRNA-2026-10-26_MRNA_ntm_ps_5y\u002FMRNA-2026-10-26_MRNA_ntm_ps_5y.png?_i=AA 3024w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1793018831\u002Fimages\u002FMRNA-2026-10-26_MRNA_ntm_ps_5y\u002FMRNA-2026-10-26_MRNA_ntm_ps_5y.png?_i=AA 600w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1200,h_800,c_scale\u002Ff_webp,q_auto\u002Fv1793018831\u002Fimages\u002FMRNA-2026-10-26_MRNA_ntm_ps_5y\u002FMRNA-2026-10-26_MRNA_ntm_ps_5y.png?_i=AA 1200w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1400,h_933,c_scale\u002Ff_webp,q_auto\u002Fv1793018831\u002Fimages\u002FMRNA-2026-10-26_MRNA_ntm_ps_5y\u002FMRNA-2026-10-26_MRNA_ntm_ps_5y.png?_i=AA 1400w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_300,h_200,c_scale\u002Ff_webp,q_auto\u002Fv1793018831\u002Fimages\u002FMRNA-2026-10-26_MRNA_ntm_ps_5y\u002FMRNA-2026-10-26_MRNA_ntm_ps_5y.png?_i=AA 300w\" sizes=\"auto, (max-width: 3024px) 100vw, 3024px\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">Moderna (MRNA): múltiplo precio\u002Fventas forward (NTM), últimos 5 años (\u003Cstrong>TIKR\u003C\u002Fstrong>)\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Al precio de esta mañana, está más cerca de 39x.\u003C\u002Fp>\n\n\n\n\u003Ch2 id=\"h-the-case-for-patience\" class=\"wp-block-heading\">El argumento a favor de la paciencia\u003C\u002Fh2>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">David Berman, director de desarrollo de Moderna, argumentó en la llamada con inversores del sábado que el beneficio crecerá. La vacuna tarda semanas en fabricarse y semanas más en hacer efecto, por lo que los dos brazos de un ensayo se siguen entre sí durante unos seis meses. En la Fase 2, la reducción del riesgo en el mismo punto del seguimiento fue del 44%. Creció al 49% a medida que esos primeros meses pesaron menos.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\"Creemos que los datos de la fase III, por esta razón, seguirán mejorando\", dijo.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Piper Sandler está de acuerdo: esta mañana elevó su precio objetivo a $230 desde $167.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Sin embargo, los analistas esperan ingresos de solo $3.34 mil millones en 2028, aproximadamente la mitad de los $6.85 mil millones de 2023.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg width=\"3024\" height=\"2016\" data-public-id=\"images\u002FMRNA-2026-10-26_MRNA_revenue_estimates_2023-2028\u002FMRNA-2026-10-26_MRNA_revenue_estimates_2023-2028.png\" loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_3024,h_2016,c_scale\u002Ff_webp,q_auto\u002Fv1793018828\u002Fimages\u002FMRNA-2026-10-26_MRNA_revenue_estimates_2023-2028\u002FMRNA-2026-10-26_MRNA_revenue_estimates_2023-2028.png?_i=AA\" alt=\"Gráfico de barras de TIKR de los ingresos de Moderna, reales y estimaciones de consenso, $ miles de millones, ejercicio fiscal 2023–2028.\" class=\"wp-post-145509 wp-image-145508\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1793018828\" data-seo=\"1\" srcset=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Ff_webp,q_auto\u002Fv1793018828\u002Fimages\u002FMRNA-2026-10-26_MRNA_revenue_estimates_2023-2028\u002FMRNA-2026-10-26_MRNA_revenue_estimates_2023-2028.png?_i=AA 3024w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1793018828\u002Fimages\u002FMRNA-2026-10-26_MRNA_revenue_estimates_2023-2028\u002FMRNA-2026-10-26_MRNA_revenue_estimates_2023-2028.png?_i=AA 600w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1200,h_800,c_scale\u002Ff_webp,q_auto\u002Fv1793018828\u002Fimages\u002FMRNA-2026-10-26_MRNA_revenue_estimates_2023-2028\u002FMRNA-2026-10-26_MRNA_revenue_estimates_2023-2028.png?_i=AA 1200w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1400,h_933,c_scale\u002Ff_webp,q_auto\u002Fv1793018828\u002Fimages\u002FMRNA-2026-10-26_MRNA_revenue_estimates_2023-2028\u002FMRNA-2026-10-26_MRNA_revenue_estimates_2023-2028.png?_i=AA 1400w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_300,h_200,c_scale\u002Ff_webp,q_auto\u002Fv1793018828\u002Fimages\u002FMRNA-2026-10-26_MRNA_revenue_estimates_2023-2028\u002FMRNA-2026-10-26_MRNA_revenue_estimates_2023-2028.png?_i=AA 300w\" sizes=\"auto, (max-width: 3024px) 100vw, 3024px\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">Moderna (MRNA): ingresos, reales y estimaciones de consenso, $ miles de millones, ejercicio fiscal 2023–2028 (\u003Cstrong>TIKR\u003C\u002Fstrong>)\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Nada en los datos del sábado argumenta a favor de reducir esas estimaciones.\u003C\u002Fp>\n\n\n\n\u003Ch2 id=\"h-great-data-steep-price\" class=\"wp-block-heading\">Grandes datos, precio elevado\u003C\u002Fh2>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Moderna se hundió con datos \"transformadores\" porque la acción estaba valorada por más de un éxito en melanoma. A cerca de 39x ventas forward, aún lo está.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Mi opinión: intismeran parece un avance real para los pacientes, pero querría los datos de supervivencia global en mano antes de pagar este múltiplo.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Por supuesto, si el beneficio crece como Berman espera, el precio de hoy podría parecer barato en retrospectiva. Merck reporta el 29 de octubre, y Moderna el 6 de noviembre.\u003C\u002Fp>\n\n\n\n\u003Ch2 id=\"h-so-what-is-moderna-stock-actually-worth\" class=\"wp-block-heading\">Entonces, ¿cuánto vale realmente la acción de Moderna?\u003C\u002Fh2>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">TIKR te permite pronosticar el precio futuro de cualquier acción en menos de un minuto. Solo ingresa algunas suposiciones en el modelo de valoración de TIKR y mira cuánto podría valer Moderna. Comienza desde las estimaciones de consenso de Wall Street, o ajusta los insumos para reflejar tu propia visión del negocio. Es gratis usarlo.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Ca href=\"https:\u002F\u002Fwww.tikr.com\u002Fvaluation-model-builder?ref=tikrblog\">Valora Moderna gratis\u003C\u002Fa>\u003C\u002Fp>\n\n\n\n\u003Ch3 id=\"h-disclaimer\" class=\"wp-block-heading\">\u003Cstrong>Descargo de responsabilidad:\u003C\u002Fstrong>\u003C\u002Fh3>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cem>Tenga en cuenta que los artículos en TIKR no pretenden servir como asesoramiento de inversión o financiero de TIKR o nuestro equipo de contenido, ni son recomendaciones para comprar o vender acciones. Creamos nuestro contenido basándonos en los datos de inversión de TIKR Terminal y las estimaciones de los analistas. Nuestro análisis podría no incluir noticias recientes de la empresa o actualizaciones importantes. TIKR no tiene posición en ninguna de las acciones mencionadas. ¡Gracias por leer y feliz inversión!\u003C\u002Fem>\u003C\u002Fp>",774,"es","\u002Fblog\u002Fmoderna-sinks-another-8-even-as-lead-investigator-calls-melanoma-vaccine-data-transformational","moderna-sinks-another-8-even-as-lead-investigator-calls-melanoma-vaccine-data-transformational","images\u002Fgrim-older-man-falling-red-chart\u002Fgrim-older-man-falling-red-chart","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792780116\u002Fimages\u002Fgrim-older-man-falling-red-chart\u002Fgrim-older-man-falling-red-chart.png?_i=AA",{"altText":236,"imageCredit":237},"Moderna Sinks Another 8% Even as Lead Investigator Calls Melanoma Vaccine Data “Transformational”","BackyardProduction from Getty Images via Canva]",{"name":239,"slug":240,"role":241,"roleTitle":242,"biography":242,"avatar":242,"socialMediaLinks":243},"Roxanna Maglangit","roxtikr","author","",[],{"name":239,"slug":240,"role":245,"roleTitle":242,"biography":242,"avatar":242,"socialMediaLinks":246},"editor",[],[248],{"name":249,"slug":250,"uri":251,"description":242,"postsCount":252},"Inversión General","general-investing","\u002Fblog\u002Fcategory\u002Fgeneral-investing",0,[],{"title":236,"metaDesc":255,"opengraphDescription":255,"twitterTitle":236,"twitterDescription":255},"A real win for melanoma patients, and still a pricey stock",{"title":257,"description":255,"twitterTitle":257,"twitterDescription":255,"author":239,"articlePublisher":258,"articlePublishedTime":226,"articleModifiedTime":226,"twitterLabel1":259,"twitterData1":260,"ogTitle":257,"ogDescription":255,"ogUrl":231,"ogImage":234,"ogImageWidth":261,"ogImageHeight":262,"ogImageSecureUrl":234,"ogImageAlt":236,"twitterImage":234},"Moderna Sinks Another 8% Even as Lead Investigator Calls Melanoma Vaccine Data “Transformational”","TIKR.com","Tiempo de lectura estimado","6 minutes",1200,630,[264,279,296,311,326],{"id":252,"title":265,"date":266,"excerpt":267,"wordCount":268,"uri":269,"slug":270,"cloudinaryAssetId":271,"featuredImageOriginalUrl":272,"featuredImageMetadata":273,"author":274,"categories":276,"relatedPosts":278},"Lumentum Gana un 3% mientras StoneX Inicia Cobertura con Recomendación de Compra y Objetivo de $1,200: \"Puntos Críticos de Escasez\"","2026-10-26 19:24:22","StoneX no se está arriesgando aquí",730,"\u002Fblog\u002Flumentum-gains-3-as-stonex-starts-at-buy-with-1200-target-critical-scarcity-points","lumentum-gains-3-as-stonex-starts-at-buy-with-1200-target-critical-scarcity-points","images\u002Fconfident-man-rising-green-chart\u002Fconfident-man-rising-green-chart","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792770636\u002Fimages\u002Fconfident-man-rising-green-chart\u002Fconfident-man-rising-green-chart.png?_i=AA",{"altText":265},{"name":239,"slug":240,"role":241,"roleTitle":242,"biography":242,"avatar":242,"socialMediaLinks":275},[],[277],{"name":249,"slug":250,"uri":251,"description":242,"postsCount":252},[],{"id":252,"title":280,"date":281,"excerpt":282,"wordCount":283,"uri":284,"slug":285,"cloudinaryAssetId":286,"featuredImageOriginalUrl":287,"featuredImageMetadata":288,"author":289,"categories":293,"relatedPosts":295},"Circle Cae un 7% mientras Mizuho Advierte de un \"Riesgo Marcado\" por los Agentes de IA y Reduce su Precio Objetivo a $43","2026-10-26 19:07:47","Mizuho preguntó a los agentes de IA dónde mantener efectivo, y no eligieron USDC.",701,"\u002Fblog\u002Fcircle-sinks-7-as-mizuho-warns-of-marked-risk-from-ai-agents-cuts-target-to-43","circle-sinks-7-as-mizuho-warns-of-marked-risk-from-ai-agents-cuts-target-to-43","images\u002F5-9_118780a9ab7\u002F5-9_118780a9ab7","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1784630659\u002Fimages\u002F5-9_118780a9ab7\u002F5-9_118780a9ab7.png?_i=AA",{"altText":280},{"name":290,"slug":291,"role":241,"roleTitle":242,"biography":242,"avatar":242,"socialMediaLinks":292},"Gian Estrada","giantikr",[],[294],{"name":249,"slug":250,"uri":251,"description":242,"postsCount":252},[],{"id":252,"title":297,"date":298,"excerpt":299,"wordCount":300,"uri":301,"slug":302,"cloudinaryAssetId":303,"featuredImageOriginalUrl":304,"featuredImageMetadata":305,"author":306,"categories":308,"relatedPosts":310},"Xencor se dispara un 31% tras datos de ensayo en cáncer renal que muestran \"actividad antitumoral impresionante\"","2026-10-26 18:55:19","Solo 11 pacientes, pero qué comienzo.",742,"\u002Fblog\u002Fxencor-soars-31-on-kidney-cancer-trial-data-showing-impressive-antitumor-activity","xencor-soars-31-on-kidney-cancer-trial-data-showing-impressive-antitumor-activity","images\u002Fcheering-woman-rising-green-chart\u002Fcheering-woman-rising-green-chart","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1793020037\u002Fimages\u002Fcheering-woman-rising-green-chart\u002Fcheering-woman-rising-green-chart.png?_i=AA",{"altText":297},{"name":239,"slug":240,"role":241,"roleTitle":242,"biography":242,"avatar":242,"socialMediaLinks":307},[],[309],{"name":249,"slug":250,"uri":251,"description":242,"postsCount":252},[],{"id":252,"title":312,"date":313,"excerpt":314,"wordCount":315,"uri":316,"slug":317,"cloudinaryAssetId":318,"featuredImageOriginalUrl":319,"featuredImageMetadata":320,"author":321,"categories":323,"relatedPosts":325},"Range Resources se dispara un 11% tras la adquisición de EQT en acciones, creando \"una compañía energética imprescindible\"","2026-10-26 18:53:00","Los tenedores de Range ahora son tenedores de EQT, para bien o para mal",721,"\u002Fblog\u002Frange-resources-soars-11-on-eqts-all-stock-takeover-creating-a-must-own-energy-company","range-resources-soars-11-on-eqts-all-stock-takeover-creating-a-must-own-energy-company","images\u002Fshocked-man-rising-green-chart\u002Fshocked-man-rising-green-chart","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1793020221\u002Fimages\u002Fshocked-man-rising-green-chart\u002Fshocked-man-rising-green-chart.png?_i=AA",{"altText":312},{"name":239,"slug":240,"role":241,"roleTitle":242,"biography":242,"avatar":242,"socialMediaLinks":322},[],[324],{"name":249,"slug":250,"uri":251,"description":242,"postsCount":252},[],{"id":252,"title":327,"date":328,"excerpt":329,"wordCount":330,"uri":331,"slug":332,"cloudinaryAssetId":-1,"featuredImageOriginalUrl":333,"featuredImageMetadata":334,"author":335,"categories":337,"relatedPosts":339},"Barclays Sigue Viendo un 100% de Potencial de Alza para Oracle. Así es Como Llega a los $252","2026-10-26 18:50:58","Las matemáticas funcionan, solo que no en un año",746,"\u002Fblog\u002Fbarclays-still-sees-100-upside-for-oracle-heres-how-it-gets-to-252","barclays-still-sees-100-upside-for-oracle-heres-how-it-gets-to-252","https:\u002F\u002Ftikr1.wpengine.com\u002Fwp-content\u002Fuploads\u002F2026\u002F10\u002FOracleStock-600x400.png",{"altText":327},{"name":239,"slug":240,"role":241,"roleTitle":242,"biography":242,"avatar":242,"socialMediaLinks":336},[],[338],{"name":249,"slug":250,"uri":251,"description":242,"postsCount":252},[],[341,361,376,390],{"id":252,"title":342,"date":343,"excerpt":344,"wordCount":345,"uri":346,"slug":347,"cloudinaryAssetId":348,"featuredImageOriginalUrl":349,"featuredImageMetadata":350,"author":351,"categories":355,"relatedPosts":360},"Subió un 13% en los últimos 12 meses, ¿puede la acción de Arista Networks ofrecer mejores rendimientos en 2026?","2026-10-26 12:57:00","Las acciones de Arista han subido un 10% en un año. Vea lo que el Modelo de Valoración de TIKR dice sobre el potencial alcista de ANET, con un precio objetivo de $275 para diciembre de 2028.",1099,"\u002Fblog\u002Farista-networks-stock-valuation-anet-2026","arista-networks-stock-valuation-anet-2026","images\u002FANET-stock-@Jirsak-from-Getty-Images-Pro-via-Canva-@Africa-images-via-Canva\u002FANET-stock-@Jirsak-from-Getty-Images-Pro-via-Canva-@Africa-images-via-Canva","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1793010558\u002Fimages\u002FANET-stock-@Jirsak-from-Getty-Images-Pro-via-Canva-@Africa-images-via-Canva\u002FANET-stock-@Jirsak-from-Getty-Images-Pro-via-Canva-@Africa-images-via-Canva.png?_i=AA",{"altText":342},{"name":352,"slug":353,"role":241,"roleTitle":242,"biography":242,"avatar":242,"socialMediaLinks":354},"Aditya Raghunath","adityatikr",[],[356],{"name":357,"slug":358,"uri":359,"description":242,"postsCount":252},"Valoración","valuation","\u002Fblog\u002Fcategory\u002Fvaluation",[],{"id":252,"title":362,"date":363,"excerpt":364,"wordCount":365,"uri":366,"slug":367,"cloudinaryAssetId":368,"featuredImageOriginalUrl":369,"featuredImageMetadata":370,"author":371,"categories":373,"relatedPosts":375},"Con una caída del 48% en los últimos 12 meses, ¿puede la acción de SoFi ofrecer mejores resultados en 2026?","2026-10-26 12:45:00","La acción de SoFi ha caído un 51% en un año. Descubre lo que el Modelo de Valoración de TIKR dice sobre el potencial alcista de SOFI, con un precio objetivo de $22 para diciembre de 2028.",1081,"\u002Fblog\u002Fsofi-stock-valuation-sofi-2026","sofi-stock-valuation-sofi-2026","images\u002FSOFI-stock-@AKKI-from-AKKI-JOHN-via-Canva-@MCCAIG-from-Getty-Images-Signature-via-Canva\u002FSOFI-stock-@AKKI-from-AKKI-JOHN-via-Canva-@MCCAIG-from-Getty-Images-Signature-via-Canva","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1793015325\u002Fimages\u002FSOFI-stock-@AKKI-from-AKKI-JOHN-via-Canva-@MCCAIG-from-Getty-Images-Signature-via-Canva\u002FSOFI-stock-@AKKI-from-AKKI-JOHN-via-Canva-@MCCAIG-from-Getty-Images-Signature-via-Canva.png?_i=AA",{"altText":362},{"name":352,"slug":353,"role":241,"roleTitle":242,"biography":242,"avatar":242,"socialMediaLinks":372},[],[374],{"name":357,"slug":358,"uri":359,"description":242,"postsCount":252},[],{"id":252,"title":377,"date":363,"excerpt":378,"wordCount":379,"uri":380,"slug":381,"cloudinaryAssetId":382,"featuredImageOriginalUrl":383,"featuredImageMetadata":384,"author":385,"categories":387,"relatedPosts":389},"Con un aumento de solo el 9% en los últimos 12 meses, ¿puede la acción de Palantir ofrecer mejores rendimientos en 2026?","La acción de Palantir solo ha subido un 4% en un año. Mira lo que dice el Modelo de Valoración de TIKR sobre el potencial alcista de PLTR, con un objetivo de $529 para diciembre de 2028.",1024,"\u002Fblog\u002Fpalantir-stock-valuation-pltr-2026","palantir-stock-valuation-pltr-2026","images\u002FPLTR-stock-@surachet_shotivaranon-from-surachetshs-Images-via-Canva-@SORAPOP-UDOMSRI-from-Sorapop-Udomsri-via-Canva_1454044a26c\u002FPLTR-stock-@surachet_shotivaranon-from-surachetshs-Images-via-Canva-@SORAPOP-UDOMSRI-from-Sorapop-Udomsri-via-Canva_1454044a26c","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1793003212\u002Fimages\u002FPLTR-stock-@surachet_shotivaranon-from-surachetshs-Images-via-Canva-@SORAPOP-UDOMSRI-from-Sorapop-Udomsri-via-Canva_1454044a26c\u002FPLTR-stock-@surachet_shotivaranon-from-surachetshs-Images-via-Canva-@SORAPOP-UDOMSRI-from-Sorapop-Udomsri-via-Canva_1454044a26c.png?_i=AA",{"altText":377},{"name":352,"slug":353,"role":241,"roleTitle":242,"biography":242,"avatar":242,"socialMediaLinks":386},[],[388],{"name":357,"slug":358,"uri":359,"description":242,"postsCount":252},[],{"id":252,"title":391,"date":392,"excerpt":393,"wordCount":394,"uri":395,"slug":396,"cloudinaryAssetId":397,"featuredImageOriginalUrl":398,"featuredImageMetadata":399,"author":400,"categories":402,"relatedPosts":404},"Con una caída del 56% en los últimos 12 meses, ¿puede la acción de AppLovin ofrecer mejores rendimientos en 2026?","2026-10-26 12:33:00","La acción de AppLovin ha caído un 60% en un año. Descubre lo que el Modelo de Valoración de TIKR dice sobre el potencial alcista de APP, con un precio objetivo de $366 para diciembre de 2028.",1139,"\u002Fblog\u002Fapplovin-stock-valuation-app-2026","applovin-stock-valuation-app-2026","images\u002FAPP-stock-@juststock-from-Getty-Images-via-Canva-@maxkabakov-from-Getty-Images-via-Canva_14548356cd2\u002FAPP-stock-@juststock-from-Getty-Images-via-Canva-@maxkabakov-from-Getty-Images-via-Canva_14548356cd2","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1793013215\u002Fimages\u002FAPP-stock-@juststock-from-Getty-Images-via-Canva-@maxkabakov-from-Getty-Images-via-Canva_14548356cd2\u002FAPP-stock-@juststock-from-Getty-Images-via-Canva-@maxkabakov-from-Getty-Images-via-Canva_14548356cd2.png?_i=AA",{"altText":391},{"name":352,"slug":353,"role":241,"roleTitle":242,"biography":242,"avatar":242,"socialMediaLinks":401},[],[403],{"name":357,"slug":358,"uri":359,"description":242,"postsCount":252},[]]